Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. Devos D, Moreau C, Maltete D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destee A, Duhamel A, Bordet R, Defebvre L, & Dujardin K J. Neurol. Neurosurg. Psychiatry, 85:668-674, 2014.
Paper doi bibtex @article{devos_d_rivastigmine_2014,
title = {Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial},
volume = {85},
issn = {0022-3050},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24218528},
DOI = {10.1136/jnnp-2013-306439},
Language = {English},
Journal = {J. Neurol. Neurosurg. Psychiatry},
author = {{Devos D} and {Moreau C} and {Maltete D} and {Lefaucheur R} and {Kreisler A} and {Eusebio A} and {Defer G} and {Ouk T} and {Azulay JP} and {Krystkowiak P} and {Witjas T} and {Delliaux M} and {Destee A} and {Duhamel A} and {Bordet R} and {Defebvre L} and {Dujardin K}},
year = {2014},
keywords = {Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index},
pages = {668-674}
}
Downloads: 0
{"_id":"m4dJhh2Xy4ANmotxC","bibbaseid":"devosd-moreauc-malteted-lefaucheurr-kreislera-eusebioa-deferg-oukt-etal-rivastigmineinapatheticbutdementiaanddepressionfreepatientswithparkinsonsdiseaseadoubleblindplacebocontrolledrandomisedclinicaltrial-2014","authorIDs":[],"author_short":["Devos D","Moreau C","Maltete D","Lefaucheur R","Kreisler A","Eusebio A","Defer G","Ouk T","Azulay JP","Krystkowiak P","Witjas T","Delliaux M","Destee A","Duhamel A","Bordet R","Defebvre L","Dujardin K"],"bibdata":{"bibtype":"article","type":"article","title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial","volume":"85","issn":"0022-3050","url":"http://www.ncbi.nlm.nih.gov/pubmed/24218528","doi":"10.1136/jnnp-2013-306439","language":"English","journal":"J. Neurol. Neurosurg. Psychiatry","author":[{"firstnames":[],"propositions":[],"lastnames":["Devos D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Moreau C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Maltete D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lefaucheur R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kreisler A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Eusebio A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Defer G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ouk T"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Azulay JP"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Krystkowiak P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Witjas T"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Delliaux M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Destee A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bordet R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Defebvre L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dujardin K"],"suffixes":[]}],"year":"2014","keywords":"Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index","pages":"668-674","bibtex":"@article{devos_d_rivastigmine_2014,\r\ntitle = {Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial},\r\nvolume = {85},\r\nissn = {0022-3050},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/24218528},\r\nDOI = {10.1136/jnnp-2013-306439},\r\nLanguage = {English},\r\nJournal = {J. Neurol. Neurosurg. Psychiatry},\r\nauthor = {{Devos D} and {Moreau C} and {Maltete D} and {Lefaucheur R} and {Kreisler A} and {Eusebio A} and {Defer G} and {Ouk T} and {Azulay JP} and {Krystkowiak P} and {Witjas T} and {Delliaux M} and {Destee A} and {Duhamel A} and {Bordet R} and {Defebvre L} and {Dujardin K}},\r\nyear = {2014},\r\nkeywords = {Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index},\r\npages = {668-674}\r\n}\r\n\r\n","author_short":["Devos D","Moreau C","Maltete D","Lefaucheur R","Kreisler A","Eusebio A","Defer G","Ouk T","Azulay JP","Krystkowiak P","Witjas T","Delliaux M","Destee A","Duhamel A","Bordet R","Defebvre L","Dujardin K"],"key":"devos_d_rivastigmine_2014","id":"devos_d_rivastigmine_2014","bibbaseid":"devosd-moreauc-malteted-lefaucheurr-kreislera-eusebioa-deferg-oukt-etal-rivastigmineinapatheticbutdementiaanddepressionfreepatientswithparkinsonsdiseaseadoubleblindplacebocontrolledrandomisedclinicaltrial-2014","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/24218528"},"keyword":["Activities of Daily Living","Adult","Aged","Apathy*","Cholinesterase Inhibitors/therapeutic use*","Dementia/diagnosis","Depression/diagnosis","Double-Blind Method","Female","Humans","Male","Middle Aged","Neuroprotective Agents/therapeutic use*","Parkinson Disease/drug therapy*","Parkinson Disease/psychology*","Phenylcarbamates/therapeutic use*","Prospective Studies","Rivastigmine","Severity of Illness Index"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.057Z","downloads":0,"keywords":["activities of daily living","adult","aged","apathy*","cholinesterase inhibitors/therapeutic use*","dementia/diagnosis","depression/diagnosis","double-blind method","female","humans","male","middle aged","neuroprotective agents/therapeutic use*","parkinson disease/drug therapy*","parkinson disease/psychology*","phenylcarbamates/therapeutic use*","prospective studies","rivastigmine","severity of illness index"],"search_terms":["rivastigmine","apathetic","dementia","depression","free","patients","parkinson","disease","double","blind","placebo","controlled","randomised","clinical","trial","devos d","moreau c","maltete d","lefaucheur r","kreisler a","eusebio a","defer g","ouk t","azulay jp","krystkowiak p","witjas t","delliaux m","destee a","duhamel a","bordet r","defebvre l","dujardin k"],"title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial","year":2014,"dataSources":["Tt6zYqvN5kE3wbwiR"]}